Dr Reddy's Laboratories Current Ratio 2006-2019 | RDY

Current and historical current ratio for Dr Reddy's Laboratories (RDY) from 2006 to 2019. Current ratio can be defined as a liquidity ratio that measures a company's ability to pay short-term obligations. Dr Reddy's Laboratories current ratio for the three months ending June 30, 2019 was 1.90.
Dr Reddy's Laboratories Current Ratio Historical Data
Date Current Assets Current Liabilities Current Ratio
2019-06-30 $1.68B $0.89B 1.90
2019-03-31 $1.66B $0.86B 1.92
2018-12-31 $1.62B $0.90B 1.81
2018-09-30 $1.59B $0.98B 1.62
2018-06-30 $1.68B $1.03B 1.64
2018-03-31 $1.68B $1.07B 1.57
2017-12-31 $1.72B $1.15B 1.50
2017-09-30 $1.58B $1.08B 1.46
2017-06-30 $1.55B $1.01B 1.53
2017-03-31 $1.55B $1.31B 1.18
2016-12-31 $1.55B $1.40B 1.11
2016-09-30 $1.50B $1.34B 1.12
2016-06-30 $1.51B $1.00B 1.52
2016-03-31 $1.81B $0.98B 1.85
2015-12-31 $1.80B $0.96B 1.89
2015-09-30 $1.77B $1.00B 1.77
2015-06-30 $1.82B $1.02B 1.79
2015-03-31 $1.92B $1.03B 1.87
2014-12-31 $1.77B $0.93B 1.91
2014-09-30 $1.73B $0.88B 1.96
2014-06-30 $1.76B $0.88B 2.00
2014-03-31 $1.73B $0.90B 1.92
2013-12-31 $1.65B $0.91B 1.80
2013-09-30 $1.55B $0.88B 1.77
2013-06-30 $1.54B $1.00B 1.54
2013-03-31 $1.57B $0.98B 1.60
2012-12-31 $1.54B $0.92B 1.67
2012-09-30 $1.49B $0.90B 1.66
2012-06-30 $1.34B $0.85B 1.58
2012-03-31 $1.38B $0.85B 1.61
2011-12-31 $1.36B $0.97B 1.39
2011-09-30 $1.16B $1.05B 1.10
2011-06-30 $1.09B $0.92B 1.19
2011-03-31 $1.07B $0.92B 1.16
2010-12-31 $0.92B $0.74B 1.25
2010-09-30 $0.91B $0.71B 1.28
2010-06-30 $0.92B $0.65B 1.42
2010-03-31 $0.94B $0.65B 1.45
2009-12-31 $0.80B $0.47B 1.70
2009-09-30 $0.78B $0.50B 1.57
2009-06-30 $0.82B $0.53B 1.55
2009-03-31 $0.77B $0.52B 1.47
2008-12-31 $0.79B $0.58B 1.35
2008-09-30 $0.82B $0.62B 1.32
2008-06-30 $0.79B $0.54B 1.45
2008-03-31 $0.87B $0.49B 1.79
2007-12-31 $0.84B $0.44B 1.91
2007-09-30 $0.84B $0.43B 1.95
2007-06-30 $0.77B $0.37B 2.06
2007-03-31 $0.87B $0.43B 2.02
2006-12-31 $0.84B $0.54B 1.54
2006-09-30 $0.64B $0.59B 1.09
2006-06-30 $0.56B $0.54B 1.04
2006-03-31 $0.45B $0.42B 1.07
2005-12-31 $0.43B $0.21B 2.03
2005-09-30 $0.48B $0.21B 2.31
2005-06-30 $0.46B $0.20B 2.28
2005-03-31 $0.42B $0.17B 2.42
Sector Industry Market Cap Revenue
Medical Medical - Generic Drugs $5.851B $2.225B
Doctor Reddy's is an emerging global pharmaceutical company with proven research capabilities. They are vertically integrated with a presence across the pharmaceutical value chain. They produce finished dosage forms, active pharmaceutical ingredients and biotechnology products and market them globally, with focus on India, US, Europe and Russia. They conduct research in the areas of cancer, diabetes, cardiovascular, inflammation and bacterial infection
Stock Name Country Market Cap PE Ratio
Allergan (AGN) Ireland $51.911B 9.47
Mylan (MYL) United Kingdom $9.559B 4.21
Bausch Health Cos (BHC) Canada $7.495B 5.00
Teva Pharmaceutical Industries (TEVA) Israel $6.999B 2.75
ASPEN PHARMACR (APNHY) South Africa $2.022B 0.00
Supernus Pharmaceuticals (SUPN) United States $1.422B 13.90
Amphastar Pharmaceuticals (AMPH) United States $1.010B 49.72
Voyager Therapeutics (VYGR) United States $0.791B 0.00
Homology Medicines (FIXX) United States $0.738B 0.00
CymaBay Therapeutics (CBAY) United States $0.400B 0.00
Mallinckrodt Public Limited Company (MNK) United Kingdom $0.343B 0.47
Akorn (AKRX) United States $0.341B 0.00
Assembly Biosciences (ASMB) United States $0.321B 0.00
Progenics Pharmaceuticals (PGNX) United States $0.320B 0.00
Zynerba Pharmaceuticals (ZYNE) United States $0.260B 0.00
Adamas Pharmaceuticals (ADMS) United States $0.178B 0.00
Sol-Gel Technologies (SLGL) Israel $0.161B 0.00
Aquinox Pharmaceuticals (NLTX) Canada $0.093B 0.00
Teligent (TLGT) United States $0.037B 0.00
China Pharma Holdings (CPHI) China $0.011B 0.00